Quickstart Highlights

Ovagen is a synthetic ultrashort tripeptide (Glu-Asp-Leu; EDL) studied as a bioregulator of gastrointestinal and liver tissues^[1]. In vitro studies demonstrate that EDL increases cell proliferation and modulates aging-related gene markers (p16, p21, p53, SIRT-6) in renal cell cultures^[2]. No controlled human trials exist; available data are preclinical and cell-based. This educational protocol presents a once-daily subcutaneous approach with gradual titration using microgram-level dosing.

• Reconstitute: Add 2.0 mL bacteriostatic water → 10 mg/mL (10,000 μg/mL) concentration.
• Typical daily range: 10–150 μg once daily (gradual titration over 16 weeks).
• Easy measuring: At 10 mg/mL, 1 unit = 0.01 mL = 100 μg on a U-100 insulin syringe.
• Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles.

Protocol Overview

Concise summary of the once-daily regimen.

• Goal: Support gastrointestinal and hepatic tissue bioregulation over time^[1].
• Schedule: Daily subcutaneous injections for 16 weeks with gradual titration.
• Dose Range: 10–150 μg daily with slow escalation.
• Reconstitution: 2.0 mL per 20 mg vial (10 mg/mL) for precise microgram measurements.
• Storage: Lyophilized frozen; reconstituted refrigerated; avoid repeated freeze–thaw.

Dosing Protocol

Suggested daily titration approach.

• Start: 10 μg daily for Weeks 1–2; increase to 20 μg for Weeks 3–4.
• Escalate: 50 μg for Weeks 5–6; then 100 μg for Weeks 7–8.
• Maintenance: 100–150 μg daily for Weeks 9–16.
• Frequency: Once per day (subcutaneous).
• Timing: Any consistent time; rotate injection sites.

Storage Instructions

Proper storage preserves peptide quality^[4][5].

• Lyophilized: Store at −20 °C (−4 °F) or colder in dry, dark conditions; for long-term stability, −80 °C (−112 °F) is optimal.
• Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); use within a few days or aliquot and freeze to minimize hydrolysis.
• Do not store thawed solution longer than 1–2 days at 2–8 °C; avoid freeze–thaw cycles.
• Allow vials to reach room temperature before opening to reduce condensation uptake.

Important Notes

Practical considerations for consistency and safety.

• Use new sterile insulin syringes (30-unit or 50-unit preferred for low-volume accuracy); dispose in a sharps container.
• Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation.
• Inject slowly; wait a few seconds before withdrawing the needle.
• Document daily dose and site rotation to maintain consistency.
• Label the vial with date/time of reconstitution, diluent volume, final concentration, and initials^[4].

How This Works

Ovagen (EDL) is an ultrashort peptide believed to enter cells and bind DNA, thereby modulating gene expression and protein synthesis^[1][6]. In vitro studies show EDL increases cell proliferation and alters aging-related gene markers (p16, p21, p53, SIRT-6) in renal cell cultures, suggesting cytoprotective effects^[2]. Such ultrashort peptides are known to influence cell differentiation, proliferation, and apoptosis via gene regulation^[3]. Additionally, EDL has been identified as an HIV-1 protease inhibitor with binding affinity in the enzyme active site^[7].

Potential Benefits & Side Effects

Observations from preclinical and in vitro literature (no controlled human trials available).

• May support gastrointestinal and hepatic tissue bioregulation based on ultrashort peptide bioregulator research^[1].
• In vitro studies indicate potential cytoprotective effects via modulation of aging-related gene expression^[2].
• Ultrashort peptides generally exhibit rapid metabolism and low immunogenicity^[6].
• Side effects are not well characterized due to lack of human clinical data; mild injection-site reactions (redness/itch) may occur with subcutaneous administration.

Lifestyle Factors

Complementary strategies for best outcomes.

• Pair with a balanced diet supporting gastrointestinal and liver health.
• Maintain regular physical activity to support overall metabolic function.
• Prioritize sleep and stress management to support adherence and recovery.
• Avoid excessive alcohol and hepatotoxic substances during the protocol.

Injection Technique

General subcutaneous guidance from clinical best-practice resources^[8].

• Clean the vial stopper and skin with 60–70% alcohol; allow to dry^[8].
• Pinch a skinfold; insert the needle at 45–90° into subcutaneous tissue^[9][10].
• Do not aspirate for subcutaneous injections; inject slowly and steadily^[8].
• Rotate sites systematically (abdomen, thighs, upper arms) to avoid tissue irritation; keep at least ~2 cm between injections on the same area.
• Use a 23–25 gauge needle (5/8″ length) or standard insulin syringe needles (28–31G)^[10].

Recommended Source

Note: Product availability and specifications subject to change. Verify current product details on supplier website.

Shop at Amino Labs

References